课题基金 / 基金详情

项目摘要

项目成果

STEPHEN F VATNER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Improving exercise tolerance, one of the major goals of physicians treating patients with cardiovascular disease, can be achieved either by improving cardiac output and blood flow to skeletal muscle, or by improving energy metabolism in skeletal muscle, or both. However, less is known regarding specific molecular pathways that might be approached therapeutically to improve exercise tolerance. In the past, we have demonstrated that the adenylyl cyclase type 5 (AC5) knockout (KO) mouse lives one third longer than wild type and is protected against aging induced cardiomyopathy, and the development of heart failure induced by either chronic catecholamine or pressure overload stress. The current project is based on these studies and our preliminary data demonstrating that AC5 KO mice exhibit increased exercise capacity. Our overall hypothesis is that AC5 is a critical enzyme affecting stress resistance and exercise capacity. The goal of this project is to examine mechanisms involved in AC5 inhibition, which could lead to a novel approach to improve exercise performance. There are two major hypotheses: HYPOTHESIS A: AC5 inhibition permits enhanced exercise performance due to improved limb blood flow through enhanced vasodilator mechanisms or angiogenesis, whereas improved cardiac function and cardiac output are less likely mechanisms. HYPOTHESIS B: AC5 inhibition permits enhanced exercise performance due to improved mitochondrial function and/or resistance to oxidative stress and/or improved glucose utilization. The implications for Public Health are clear: improving exercise tolerance will have broad significance for aging, heart disease, most other diseases and even for the young, healthy population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Pharmacological Inhibitor of Adenylyl Cyclase Type 5 to Treat Alzheimer's Disease
  • 批准号:
    10608477
  • 项目类别:
  • 资助金额:
    $25.21万
  • 财政年份:
    2022
  • 负责人:
    STEPHEN F VATNER
  • 依托单位:
Skeletal Muscle and Brown Adipose Mechanisms Mediating Cardiovascular Risk Factor Protection in RGS14 KO
  • 批准号:
    9900047
  • 项目类别:
  • 资助金额:
    $53.43万
  • 财政年份:
    2017
  • 负责人:
    STEPHEN F VATNER
  • 依托单位:
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk
  • 批准号:
    9900045
  • 项目类别:
  • 资助金额:
    $56.45万
  • 财政年份:
    2017
  • 负责人:
    STEPHEN F VATNER
  • 依托单位:
Vascular Protection in Hibernating Woodchucks
  • 批准号:
    9020511
  • 项目类别:
  • 资助金额:
    $45.47万
  • 财政年份:
    2016
  • 负责人:
    STEPHEN F VATNER
  • 依托单位:
海外基金